Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Breast Cancer
Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00916162 - Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy | Biotech Hunter | Biotech Hunter